Review decisions
Showing 420 results of 1553 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687527077098
Product Type: Drug
Control Number: 264582
DIN(s): 02423898, 02470608, 02480786
Manufacturer: Pfizer Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-26
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686747902362
Product Type: Drug
Control Number: 266313
DIN(s): 02502143
Manufacturer: Gilead Sciences Canada Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2022-08-02
Decision / Authorization Date: 2023-06-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1685545138786
Product Type: Drug
Control Number: 264995
DIN(s): 02538164
Manufacturer: Emergent Travel Health Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-06-08
Decision / Authorization Date: 2023-05-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686583434436
Product Type: Drug
Control Number: 256724
DIN(s): 02480018
Manufacturer: Eli Lilly Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-09-16
Decision / Authorization Date: 2023-06-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722278310406
Product Type: Drug
Control Number: 275576
DIN(s): 02243721, 02531445
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-24
Decision / Authorization Date: 2024-04-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1684415510472
Product Type: Drug
Control Number: 273747
DIN(s): 02532352
Manufacturer: ModernaTX, Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2023-03-29
Decision / Authorization Date: 2023-05-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687801209635
Product Type: Drug
Control Number: 268412
DIN(s): 02537745
Manufacturer: Rhythm Pharmaceuticals Inc.
Submission Type: New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-10-04
Decision / Authorization Date: 2023-05-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686686460648
Product Type: Drug
Control Number: 264612
DIN(s): 02495155, 02520893
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-27
Decision / Authorization Date: 2023-05-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1684156979784
Product Type: Drug
Control Number: 264318
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-16
Decision / Authorization Date: 2023-04-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1685724874375
Product Type: Drug
Control Number: 262756
DIN(s): 02489597
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-24
Decision / Authorization Date: 2023-03-21